Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimiset M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Axa Life Sciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimiset M 1mg/500mg Tablet

Diabetic patients using Metformin/Glimepiride 1mg/500mg tablets should understand that this antidiabetic medication combines two active components to manage type 2 diabetes in adults. This dual-action formulation regulates blood sugar, requiring consistent daily use at the same time, ideally with food. Dosage is individually determined by your physician and subject to adjustment based on your blood glucose readings. Continuous use, even with seemingly controlled blood sugar, is crucial. Discontinuation without medical advice risks dangerously elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements—it does not replace—a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Common side effects include hypoglycemia (low blood sugar), manifesting as sweating, dizziness, headache, and tremors. Prompt treatment with fast-acting glucose (e.g., sugary foods or juice) is vital. Alcohol consumption should be minimized due to its hypoglycemic effect. Other possible side effects are altered taste, nausea, diarrhea, abdominal pain, headache, upper respiratory infections, and weight gain. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended under your physician's supervision.

Uses of Glimiset M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimiset M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glimiset M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Glimiset M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimiset M 1mg/500mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Glimiset M 1mg/500mg tablet with a meal.

How Glimiset M 1mg/500mg Tablet works:

Glimiset M 1mg/500mg tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimiset M 1mg/500mg tablets with alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimiset M 1mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimiset M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimiset M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimiset M 1mg/500mg tablets. Physician consultation is essential. Routine kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimiset M 1mg/500mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically recommended, while use is generally contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimiset M 1mg/500mg Tablet :

Should you forget to take a Glimiset M 1mg/500mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Glimiset M 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Glimiset M 1mg/500mg Tablet

Retain this medication within its original, securely sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Ensure its inaccessibility to children, pets, and others.
Glimiset M 1mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms might include muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Glimiset M 1mg/500mg Tablet use and seek immediate medical attention.
Glimiset M 1mg/500mg tablets contain glimepiride and metformin, acting together to manage type 2 diabetes mellitus in adults. This dual therapy enhances blood sugar control when combined with a suitable diet and physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose output and improves insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Glimiset M 1mg/500mg tablets may cause common adverse reactions including hypoglycemia (low blood sugar), altered taste perception, nausea, abdominal discomfort, diarrhea, and headache. Rare but potentially serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimiset M 1mg/500mg Tablet use can indeed lead to Vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as tingling and numbness in extremities, muscle weakness, urinary dysfunction, cognitive changes, and impaired balance. To mitigate these risks, supplemental Vitamin B12 intake at least annually is recommended by some studies.
Indeed, Glimiset M 1mg/500mg Tablets may induce hypoglycemia (low blood sugar). Manifestations of low blood sugar can encompass nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available source of sugar, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glimiset M 1mg/500mg tablets and alcohol is unsafe. Alcohol consumption with this medication may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Glimiset M 1mg/500mg Tabl...
36
MRP 44
18% off